The Science Journal of the Lander College of Arts and Sciences
Abstract
Both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are pluripotent, meaning that they can give rise to many types of cells. Consequently, they both represent incredible potential for applications in regenerative medicine and research models. This paper explores their similarities and critical molecular differences, especially in the context of tissue engineering. Through analysis of three peer-reviewed studies, the paper focuses on their respective advantages and limitations. One study used Raman spectroscopy to reveal higher nucleic acid content in iPSCs, possibly due to epigenetic memory. The second study utilized DNA methylation profiling and gene expression data to construct a scorecard system predicting cell line differentiation efficiency, highlighting subtle but consistent epigenetic differences between ESCs and iPSCs. Study III demonstrated that both hiPSCs and hESCs retain oncogenic gene expression profiles when differentiated, illustrating the need for additional research in the field. Therefore, even though iPSCs are more accessible and less ethically gray, their reprogramming-induced variability and potential for oncogenic mutations limits their clinical utility. ESCs, with greater epigenetic stability and inherent pluripotency, are therefore superior for applications in regenerative medicine.
Recommended Citation
Devora Weinstein. (2025). Embryonic Stem Cells vs Induced Pluripotent Stem Cells for Tissue Engineering. The Science Journal of the Lander College of Arts and Sciences, 19(1), 86-91. Retrieved from https://touroscholar.touro.edu/sjlcas/vol19/iss1/12
